3 Biotech

投稿咨询

官方网站：

投稿网址：

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2190-572X%5BISSN%5D

3 Biotech公布与生物技术研究和应用相关的最新研究结果，以：-医学和生物医学科学-农业-环境对这三个技术部门的关注认识到，完整的生物技术应用通常需要技术的结合。3生物技术不仅展示了生物技术的最新发展，还解决了为特定应用集成各种技术的问题和好处。3生物技术呼吁学术界和工业界的科学家和工程师关注生物技术在医药、农业和环境中的安全和有效应用。欢迎各种生物技术应用的文章，包括：-癌症和干细胞研究-基因工程与克隆-生物修复与生物降解-生物信息学与系统生物学-生物标志物和生物传感器-生物多样性和生物发现-生物机器人和生物毒素-分析生物技术与人类基因组3生物技术公司接受原创和评论文章，以及简短的研究报告、方案和方法、给编辑的注释、给编辑的信件和出版的书评。还将考虑最新的专题评论文章。所有的手稿都经过同行评审，以获得科学的质量和认可。3生物技术公司最近收到了其第一个影响因素，目前涵盖了一系列A&I服务，包括：-科学引文索引扩展-期刊引文报告/科学版-生物文摘-Biosis预览3生物科技在连续文章出版（cap）下出版，在收到作者证明后不久，接受的论文将以卷和文章编号在线出版。CAP旨在加快从接收文章到最终出版的过程，而不需要将文章放置在等待队列中。这将确保3个生物技术的所有文章都能立即提供给相关索引和抽象数据库的研究人员。

3 Biotech publishes the results of the latest research related to the study and application of biotechnology to:- Medicine and Biomedical Sciences- Agriculture- The EnvironmentThe focus on these three technology sectors recognizes that complete Biotechnology applications often require a combination of techniques. 3 Biotech not only presents the latest developments in biotechnology but also addresses the problems and benefits of integrating a variety of techniques for a particular application. 3 Biotech appeals to scientists and engineers in both academia and industry focusing on the safe and efficient application of Biotechnology to Medicine, Agriculture and the Environment.Articles from a huge variety of biotechnology applications are welcome including:- Cancer and stem cell research- Genetic engineering and cloning- Bioremediation and biodegradation- Bioinformatics and system biology- Biomarkers and biosensors- Biodiversity and biodiscovery- Biorobotics and biotoxins- Analytical biotechnology and the human genome3 Biotech accepts original and review articles as well as short research reports, protocols and methods, notes to the editor, letters to the editor and book reviews for publication. Up to date topical review articles will also be considered. All the manuscripts are peer-reviewed for scientific quality and acceptance.3 Biotech has recently received its first Impact Factor and is now covered by a range of A&I services, including:- Science Citation Index Expanded- Journal Citation Reports/Science Edition- Biological Abstracts- BIOSIS Previews3 Biotech publishes under the Continuous Article Publishing (CAP) in which accepted papers are published online with volume and article numbers shortly after receipt of authors proofs. CAP aims to speed up the process from acceptance of articles to final publication without the need for articles to be placed in a waiting line. This will ensure that all articles in 3 Biotech are immediately available for researchers in relevant indexing and abstracting databases.